STAAR Surgical(STAA) - 2025 Q3 - Quarterly Results

Form 8-K General Information This section provides administrative and identifying information for the 8-K filing, including corporate details and stock exchange listing Registrant and Filing Details This section provides the administrative and identifying information for STAAR Surgical Company's 8-K filing, including its corporate details, stock exchange listing, and confirmation of its non-emerging growth company status - The registrant is STAAR Surgical Company, incorporated in Delaware[1] Securities Registered | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------ | :---------------- | :---------------------------------------- | | Common | STAA | NASDAQ | - The registrant is not an emerging growth company[3] Reported Events and Exhibits This section details the significant events reported in the 8-K, including financial results and accompanying exhibits Item 2.02 Results of Operations and Financial Condition STAAR Surgical Company announced its preliminary net sales results for the quarter ended September 26, 2025, through a press release, which is incorporated by reference as an exhibit to this report - STAAR Surgical Company published a press release on October 20, 2025, reporting preliminary net sales results[4] - The reported results are for the quarter ended September 26, 2025[4] - The press release is filed as Exhibit 99.1 to this report[4] Item 9.01 Financial Statements and Exhibits This section lists the specific documents filed as exhibits to the 8-K report, including the press release detailing the preliminary financial results and the interactive data file Filed Exhibits | Exhibit Number | Exhibit Description | | :------------- | :---------------------------------------------------------- | | 99.1 | Press release of the Company dated October 20, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | Report Signatures This section provides formal authentication of the 8-K report through authorized signatory details Authorized Signatory Information The report is formally signed by an authorized representative of STAAR Surgical Company, confirming its submission in accordance with regulatory requirements - The report was signed on October 20, 2025[8] - Stephen C. Farrell, Chief Executive Officer, signed the report on behalf of STAAR Surgical Company[8]